Tivity Health Inc (TVTY) Return on Assets ROA from the first quarter of 2022 to first quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket
 


Tivity Health Inc   (NASDAQ: TVTY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Tivity Health Inc 's ROA from the first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Tivity Health Inc 's ROA in the first quarter of 2022?
Tivity Health Inc achieved a return on average assets (ROA) of 14.96 % in its first quarter of 2022, this is above TVTY's average return on assets of -2.28%.
Tivity Health Inc assets over the 12 months ending in its first quarter of 2022 are valued at $577 million

ROA fell compared to the fourth quarter of 2021, despite the net income growth of % from the fourth quarter of 2021.

However, within the Healthcare sector 69 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2021 from 429 to 514.

What is ROA?



Return On Assets (Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Total Assets Change 11.99 % 4.97 % -51 % -62.09 % -64.2 %
Y / Y Net Income Change -96.96 % - - -70.69 % -
Net Income (TTM) in million 86 105 119 -27 -6
Return On Assets (TTM) 14.96 % 18.68 % 21.39 % -3.71 % -0.69 %
TVTY's Total Ranking # 514 # 429 # 310 # 3208 # 2753
Total Assets (TTM) in million 589 590 620 511 526
Seq. Total Assets Change -0.21 % -4.88 % 21.44 % -2.85 % -6.46 %
Seq. Net Income Change - - 1129.71 % -56.33 % -



Return On Assets Company Ranking
Within: No.
Industry # 5
Sector # 70
Overall # 504

Return On Assets Statistics
High Average Low
20.87 %
-2.28 %
-37.08 %
(Sep 30 2021)   (Sep 30 2020)





Financial Statements
Tivity Health Inc 's Assets $ 589 million TVTY's Balance sheet
Tivity Health Inc 's Income $ 1 million Quarterly TVTY's Income Statement
TVTY's Income by Division See TVTY's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change 4.97 % -65.44 % 237.27 % -24.22 % 16.77 %
Total Assets in million 590 562 1,626 482 636
Y / Y Net Income Change - - - 55.07 % -
Net Income in million 105 -224 -287 99 64
Annual Return On Assets 17.79 % -39.8 % -17.64 % 20.5 % 10.02 %




Comment on TVTY's ROA in the fiscal year ending 2021
In the fiscal year 2021 ROA improved to 17.79 % compared to prior year, due to annual net income growth of % to $104.91 million, while value of Tivity Health Inc 's overall assets grew just by 4.97 % to $589.88 million, compared to $589.88 a year before.


More Return On Assets Ratios
TVTY's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TVTY's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TVTY's Competitors
Subscribers only: Roa for Tivity Health Inc 's Suppliers
Subscribers only: Return On Assets for TVTY's Customers

You may also want to know
TVTY's Roi TVTY's Inventory Turnover Ratio TVTY's Growth Rates TVTY's Dividend Comparisons
TVTY's Profitability Ratios TVTY's Asset Turnover Ratio TVTY's Dividend Growth
TVTY's Roe TVTY's Valuation Ratios TVTY's Financial Strength Ratios TVTY's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2022, within Healthcare Sector ROA
Effector Therapeutics Inc   40.45 %
Iteos Therapeutics Inc   40.00 %
Halozyme Therapeutics Inc   38.85 %
Avid Bioservices Inc   38.80 %
Reflect Scientific Inc  38.72 %
Molecular Templates Inc   38.05 %
Fulgent Genetics Inc   36.74 %
Rennova Health Inc   36.72 %
Carisma Therapeutics Inc   34.55 %
Regeneron Pharmaceuticals Inc   32.74 %
Innoviva Inc   32.02 %
Semler Scientific inc   30.94 %
Silo Pharma Inc  30.89 %
Co diagnostics Inc   30.58 %
Idexx Laboratories Inc  29.90 %
Elite Pharmaceuticals Inc   29.19 %
Vicarious Surgical Inc  27.93 %
Exelixis Inc   26.87 %
Integrated Biopharma Inc  26.21 %
Clene Inc   25.37 %
Maravai Lifesciences Holdings Inc   24.75 %
Mettler toledo International Inc   24.35 %
Retractable Technologies Inc  23.83 %
Nrc Health  23.77 %
Waters Corporation  22.81 %
Corcept Therapeutics Inc  21.87 %
West Pharmaceutical Services Inc   21.58 %
Lftd Partners Inc   21.38 %
Prophase Labs Inc   20.96 %
Organogenesis Holdings Inc   20.94 %


Date modified: 2026-09-08T15:10:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.